Diabetes trials are leaving out people who are most affected by diabetes, which creates a series of problems include the greater likelihood of missing rare and potentially dangerous side effects.
Substantial economic growth in the psychedelic drugs market has drawn interest from corporations and start-ups. While this may accelerate research, it also sparks concerns about conflicts of interest.
The drug has been hailed as a ‘turning point’ in Alzheimer’s treatment. But keep in mind the trial only included participants with early or mild disease. And while it slowed decline, it’s not a cure.
Health Canada continues to monitor newly approved drugs to determine if the benefits identified in the pre-market trials hold up to further scrutiny. Canadians need better access to that information.
In health care crises, researchers can avoid waiting for clinical trial results by using data from health care systems to analyze the effectiveness of treatments for COVID-19 and other illnesses.
Medicine works better when the treatments are tailored to fit each individual person’s biology and history. A first step is increasing diversity in clinical trials, but the end goal is precision medicine.
Despite technological advancements, many challenges remain in getting a drug from lab to pharmacy shelf. Reframing what is a “medicine” could expand treatment options for researchers and patients.
Overcoming the access barriers and biases that underrepresented and underserved communities face could not only improve research participation but also improve care.
According to a letter from Biden’s doctor, the president has a runny nose, mild fatigue and a slight cough. The letter also noted that Biden began taking an antiviral drug the morning he tested positive.
The COVID-19 vaccines continue to be effective against severe illness leading to hospitalization and death in all age groups, including children ages 5 to 11.
Vaibhav Upadhyay, University of Colorado Anschutz Medical Campus and Krishna Mallela, University of Colorado Anschutz Medical Campus
Existing coronavirus vaccines are not as effective against newer variants of the virus. Two vaccine experts explain how new vaccines currently in development will likely offer better protection.
Our study found a better way to treat eye problems in Indigenous communities – and some key considerations for undertaking culturally safe clinical trials.
Two Australians with bipolar have been successfully treated with poo transplants, allowing them to come off, or reduce, their medications. Here’s where the science is up to.
Drug development is a long and costly process that often ends in failure. Improving the way potential drug candidates are optimized could help boost success rates.
Professor of Bioethics & Medicine, Sydney Health Ethics, Haematologist/BMT Physician, Royal North Shore Hospital and Director, Praxis Australia, University of Sydney